({{currency.regularMarketChangePercent.toFixed(2)}}%)
  • What We Do
    • Corporate Strategy
    • Market Evaluation
    • Inorganic Growth
    • Innovation
    • Leadership Search
    • Professional Training & Development
    • Industries Served
  • BroadBranch Perspectives
  • About Us
    • Mission, Vision and Values
    • Ethics
    • Our Team
    • History
    • Diversity, Equity, and Inclusion at BroadBranch Advisors
  • Ethics
  • Work@BroadBranch
    • Our Culture
    • Current Openings
  • Contact Us
Site Logo
  • An ASGCT 2026 Summary: Key Trends Defining the Cell and Gene Therapy Market
    June 3, 2026
  • The Next Frontier: Building a More Holistic AI‑Integrated Healthcare Ecosystem
    May 20, 2026
  • Key Takeaways from Interphex 2026: Navigating Evolving Paradigms in Bioprocessing
    May 18, 2026
  • SLAS 2026: The Integrated Frontier
    March 3, 2026
  • AI in Healthcare: Tools to Improve Patient Experience
    February 11, 2026
  • AI in Healthcare: Tools to Improve Provider Satisfaction
    December 5, 2025
  • Healthcare Insights Report Fall 2025
    October 21, 2025
  • US Healthcare Trends Impacting Molecular Diagnostics (Q2 2025)
    August 15, 2025
  • Enter the Antibody Drug Conjugates (ADC) Renaissance
    June 10, 2025
  • Recent Successful Use Cases of Gen AI in Drug Discovery
    May 1, 2025
  • SLAS 2025: Pioneering the Future of Laboratory Automation
    March 13, 2025
  • Sustainability in bioprocessing
    December 10, 2024
  • 1
  • 2
  • 3
  • 4
Recent Posts
  • An ASGCT 2026 Summary: Key Trends Defining the Cell and Gene Therapy Market June 3, 2026
  • The Next Frontier: Building a More Holistic AI‑Integrated Healthcare Ecosystem May 20, 2026
  • Key Takeaways from Interphex 2026: Navigating Evolving Paradigms in Bioprocessing May 18, 2026
  • SLAS 2026: The Integrated Frontier March 3, 2026
  • AI in Healthcare: Tools to Improve Patient Experience February 11, 2026

Let’s Begin A Conversation

In about 15 minutes we can determine if our approach can provide value to your organization.

Contact Us
SERVICES
  • Corporate Strategy
  • Market Evaluation
  • Inorganic Growth
  • Innovation
  • Leadership Search
  • Professional Training & Development
BroadBranch Advisors

For over 20 years, BroadBranch has partnered with its clients across a broad spectrum of industries to solve complex business challenges. Using solid analytics, logical arguments, and fresh market perspectives, we deliver clear and actionable recommendations that drive growth and performance.

Corporate

  • Corporate Strategy
  • Market Evaluation
  • Inorganic Growth
  • Innovation
  • Leadership Search
  • Professional Training & Development

Perspectives

  • An ASGCT 2026 Summary: Key Trends Defining the Cell and Gene Therapy Market June 3, 2026
  • The Next Frontier: Building a More Holistic AI‑Integrated Healthcare Ecosystem May 20, 2026
  • Key Takeaways from Interphex 2026: Navigating Evolving Paradigms in Bioprocessing May 18, 2026

Fresh perspectives, delivered.

Sign up for the BroadBranch Newsletter

Select list(s) to subscribe to

© 2026 BroadBranch Advisors. All rights reserved

We use cookies to ensure that we give you the best experience on our website. You can view our Cookie Policy here if you'd like.Ok